Does EVOLOCUMAB Cause Swelling? 323 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 323 reports of Swelling have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.
323
Reports of Swelling with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
1
Deaths
39
Hospitalizations
How Dangerous Is Swelling From EVOLOCUMAB?
Of the 323 reports, 1 (0.3%) resulted in death, 39 (12.1%) required hospitalization, and 10 (3.1%) were considered life-threatening.
Is Swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 323 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Swelling?
ADALIMUMAB (10,906)
METHOTREXATE (10,702)
ETANERCEPT (10,467)
TOCILIZUMAB (9,420)
ABATACEPT (9,226)
LEFLUNOMIDE (8,885)
RITUXIMAB (8,477)
PREDNISONE (7,968)
HYDROXYCHLOROQUINE (7,937)
CERTOLIZUMAB PEGOL (7,748)
Which EVOLOCUMAB Alternatives Have Lower Swelling Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE